131941-21-4 Usage
Description
Pyridine, 2-(1-methylethyl)-5-nitro(9CI), also known as 2-Isopropyl-5-nitropyridine, is an organic compound belonging to the pyridine family. It is characterized by the presence of a nitro group at the 5th position and an isopropyl group at the 2nd position. Pyridine, 2-(1-methylethyl)-5-nitro(9CI) is known for its reactivity in nucleophilic reactions, particularly with electron-deficient pyridone derivatives.
Uses
Used in Chemical Synthesis:
Pyridine, 2-(1-methylethyl)-5-nitro(9CI) is used as a reagent in the chemical synthesis industry for nucleophilic reactions involving electron-deficient pyridone derivatives. Its unique structure allows it to participate in various chemical reactions, making it a valuable compound for the synthesis of complex organic molecules.
Used in Pharmaceutical Research:
In the pharmaceutical industry, Pyridine, 2-(1-methylethyl)-5-nitro(9CI) is utilized as a key intermediate in the development of new drugs. Its reactivity in nucleophilic reactions enables the creation of novel drug candidates with potential therapeutic applications.
Used in Material Science:
Pyridine, 2-(1-methylethyl)-5-nitro(9CI) also finds applications in material science, where it can be used to develop new materials with specific properties. Its ability to participate in nucleophilic reactions allows for the creation of materials with tailored characteristics, such as improved stability or enhanced reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 131941-21-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,1,9,4 and 1 respectively; the second part has 2 digits, 2 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 131941-21:
(8*1)+(7*3)+(6*1)+(5*9)+(4*4)+(3*1)+(2*2)+(1*1)=104
104 % 10 = 4
So 131941-21-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H10N2O2/c1-6(2)8-4-3-7(5-9-8)10(11)12/h3-6H,1-2H3
131941-21-4Relevant articles and documents
Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
-
Paragraph 0699, (2015/09/22)
The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
COMPOSITIONS FOR TREATMENT OF CYSTIC FIBROSIS AND OTHER CHRONIC DISEASES
-
, (2012/04/23)
The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
